Fortress Biotech, Inc. (FBIO) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Fortress Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Fortress Biotech, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$36.6 M, a 37.9% increase year-over-year.
  • Fortress Biotech, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$120 M, a 44.2% increase year-over-year.
  • Fortress Biotech, Inc. annual Operating Income (Loss) for 2023 was -$142 M, a 30.1% increase from 2022.
  • Fortress Biotech, Inc. annual Operating Income (Loss) for 2022 was -$204 M, a 7.97% decline from 2021.
  • Fortress Biotech, Inc. annual Operating Income (Loss) for 2021 was -$189 M, a 100% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$120 M -$36.6 M +$22.3 M +37.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$142 M -$19.6 M +$35 M +64.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$177 M -$13.8 M +$37 M +72.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$214 M -$50.1 M +$821 K +1.61% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$215 M -$58.9 M -$11.6 M -24.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$204 M -$54.6 M +$11.1 M +16.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$215 M -$50.7 M -$811 K -1.63% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$214 M -$50.9 M -$8.07 M -18.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$206 M -$47.3 M -$17.3 M -57.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$189 M -$65.7 M -$41.4 M -171% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$147 M -$49.9 M -$26.9 M -117% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$120 M -$42.9 M -$17.5 M -68.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$103 M -$30 M -$8.49 M -39.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$94.3 M -$24.3 M +$6.08 M +20% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$100 M -$23 M -$503 K -2.23% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$99.8 M -$25.4 M -$106 K -0.42% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$99.7 M -$21.5 M +$11.1 M +34% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$111 M -$30.4 M +$10.8 M +26.3% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 -$122 M -$22.5 M +$5.67 M +20.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$127 M -$25.3 M +$108 K +0.43% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$127 M -$32.6 M +$1.56 M +4.58% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$129 M -$41.2 M -$10.6 M -34.6% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$118 M -$28.2 M +$3.59 M +11.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$122 M -$25.4 M +$97 K +0.38% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$122 M -$34.2 M -$15 M -78.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$107 M -$30.6 M +$1.6 M +4.95% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$109 M -$31.8 M -$14.6 M -85.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$94 M -$25.5 M -$8.45 M -49.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$85.6 M -$19.1 M -$3.55 M -22.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$82 M -$32.2 M -$19.3 M -149% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$62.8 M -$17.2 M +$917 K +5.07% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$63.7 M -$17 M -$9.28 M -120% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$54.4 M -$15.6 M -$3 M -23.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$51.4 M -$13 M -$8 M -161% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$43.4 M -$18.1 M -$13.8 M -316% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$29.6 M -$7.76 M -$3 M -63% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$26.6 M -$12.6 M -$5.99 M -91% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$20.7 M -$4.96 M +$4.56 M +47.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$25.2 M -$4.35 M +$3.16 M +42.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$28.4 M -$4.76 M +$5.53 M +53.7% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$33.9 M -$6.58 M +$1.88 M +22.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$35.8 M -$9.52 M -$1.23 M -14.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$34.6 M -$7.5 M -$1.67 M -28.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$32.9 M -$10.3 M -$3.83 M -59.2% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$29.1 M -$8.46 M -$1.88 M -28.5% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$27.2 M -$8.3 M -$3.07 M -58.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$24.1 M -$5.83 M -$2.3 M -65.1% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$21.8 M -$6.47 M -$2.73 M -73% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$19.1 M -$6.58 M +$16 M +70.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$35 M -$5.23 M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$3.53 M -$1.45 M -69.6% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 -$3.74 M Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$22.5 M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$2.08 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.